🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones ◆ Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance ◆ US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position ◆ US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition ◆ ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion ◆ After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆ AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones ◆ Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance ◆ US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position ◆ US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition ◆ ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion ◆ After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆

Pharma Glossary

The definitive, structured ontology of pharmaceutical, biotechnology, and medical device acronyms, regulations, and terminology.

All Terms Biotechnology Clinical Trials Manufacturing Pharmacovigilance Quality Assurance Regulatory Affairs
A B C E G H M P R T
A
ATMP Biotechnology
Advanced Therapy Medicinal Product.
Local Context (Ireland/EU): Medicinal products based on gene therapy, somatic cell therapy, or tissue engineering. Evaluated centrally by the EMA Committee for Advanced Therapies (CAT).
B
Bioprocess Operator Biotechnology
A technical specialist responsible for monitoring bioreactors, filtration systems, and cleanroom biomanufacturing lines.
Local Context (Ireland/EU): One of the most in-demand vocational roles in Ireland's biopharma hubs.
Biosimilar Biotechnology
A biological medicine highly similar to another already approved biological medicine (the reference product).
Local Context (Ireland/EU): Regulated in Europe via strict comparative clinical and quality testing to establish therapeutic equivalence.
C
CAR-T Therapy Biotechnology
Chimeric Antigen Receptor T-cell therapy. A type of immunotherapy where a patient's T cells are genetically engineered to target cancer cells.
Local Context (Ireland/EU): Classified as an ATMP in the EU, requiring complex vein-to-vein logistical tracking and specialized hospital validation.
Cell Bank Biotechnology
A collection of ampoules containing a single pool of cells of uniform composition, stored under deep freeze conditions.
Local Context (Ireland/EU): Divided into Master Cell Bank (MCB) and Working Cell Bank (WCB) to ensure consistent cell culture starting materials.
CHO Cells Biotechnology
Chinese Hamster Ovary cells.
Local Context (Ireland/EU): The mammalian cell line most commonly used in industrial biomanufacturing to produce recombinant therapeutic proteins.
CRISPR Biotechnology
Clustered Regularly Interspaced Short Palindromic Repeats. A gene-editing technology allowing precise edits to genomic sequences.
Local Context (Ireland/EU): Used extensively in biotechnology R&D hubs in Dublin and Cork to research disease models.
E
ELISA Biotechnology
Enzyme-Linked Immunosorbent Assay. An analytical biochemistry assay that uses a solid-phase enzyme immunoassay to detect the presence of a ligand.
Local Context (Ireland/EU): Frequently used by Quality Control labs in Ireland for checking antibody concentration and purity.
Expression System Biotechnology
The combination of an expression vector and its host cell used to produce a target recombinant protein.
Local Context (Ireland/EU): Includes mammalian (CHO), bacterial (E. coli), and yeast (S. cerevisiae) systems.
G
GLP-1 Biotechnology
Glucagon-like peptide-1 receptor agonists. A class of biological drugs used to treat type 2 diabetes and obesity.
Local Context (Ireland/EU): Major manufacturing plants in Ireland are expanding lines to support high global demands for these peptides.
H
Host Cell Proteins Biotechnology
Proteins produced by the host cell line during recombinant protein expression that must be purified out of the final product.
Local Context (Ireland/EU): Monitored as critical process impurities under EU pharmacopoeia specifications.
M
Monoclonal Antibody Biotechnology
Monoclonal Antibody (mAb). Laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system.
Local Context (Ireland/EU): Form the cornerstone of biopharmaceutical manufacturing in Ireland, representing blockbuster treatments like pembrolizumab or adalimumab.
mRNA Vaccine Biotechnology
A vaccine using messenger RNA to instruct cells to produce a protein that triggers an immune response.
Local Context (Ireland/EU): Revolutionized drug delivery during the pandemic, leading to significant investment in lipid nanoparticle (LNP) tech in Ireland.
P
Plasmid Biotechnology
A small, circular, double-stranded DNA molecule that is distinct from a cell's chromosomal DNA, commonly used as a vector in gene cloning.
Local Context (Ireland/EU): Quality control departments validate plasmids for purity and sequence identity before bioprocess scale-up.
R
Recombinant DNA Biotechnology
DNA molecules formed by laboratory methods of genetic recombination to bring together genetic material from multiple sources.
Local Context (Ireland/EU): Used to engineer host cell lines (like CHO cells) for therapeutic protein synthesis.
T
Transfection Biotechnology
The process of deliberately introducing nucleic acids into eukaryotic cells to alter their genetic makeup.
Local Context (Ireland/EU): Crucial step in developing host cell lines for recombinant biomanufacturing.